Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05428761 · ClinicalTrials.gov registry record · NA
Clinical Trial to Evaluate the Effects of Two Novel Hydration Beverage Formulas on Rehydration in Healthy Adults
A NA study, sponsored by Liquid I.V..
- Completed
- Registry status
- NA
- Development phase
- 16
- Enrollment target
NCT05428761 is a NA study that has completed, run by Liquid I.V.. The registered enrollment target is 16 participants.
The verdict
NCT05428761, a NA study, has completed, sponsored by Liquid I.V..
- COMPLETED
- Registry status
- NA
- Development phase
- 16 participants
- Enrollment target
Study Summary
Dehydration lowers both physical and mental performance if it is severe enough. Performance declines are more pronounced in hot conditions or after prolonged strenuous activity such as exercise. Most individuals drink less than their sweat losses during activity, while some individuals overdrink and develop a sodium deficiency. Water and electrolyte balance must be restored as part of the recovery process after any activity that causes sweating. Plain water causes a decrease in plasma sodium concentration and osmolality, which reduces the desire to drink and increases urine production. Unless the volume ingested exceeds the loss, individuals are in net negative fluid balance throughout the recovery period due to urinary losses. When sodium and potassium are added to rehydration fluids, urine production is reduced in the hours following rehydration. Rehydration is only possible if a volume of fluid equal to or greater than the amount lost through sweat is consumed, together with adequate electrolytes. The test products for this study, TP1 and TP2, are novel hydration beverage formulas. They are an electrolyte drink mixture with five essential vitamins and three times more electrolytes than typical sports beverages. The test products create an osmotic force that permits water to be supplied to the bloodstream sooner in the digestive system by using a specific ratio of sodium, glucose, and potassium. This randomized, placebo-controlled, semi-blind, crossover study will evaluate the effects of the test products on rehydration in healthy adults.
Interventions
- OTHER Placebo
- OTHER TP1
- OTHER TP2
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 16 participants |
| Start Date | 2022-08-01 |
| Est. Completion | 2023-01-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05428761
The ClinicalTrials.gov registry entry for NCT05428761 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 16 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Liquid I.V., which has 5 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Placebo is the first listed.
NCT05428761 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05428761 about?
NCT05428761 is a clinical study titled "Clinical Trial to Evaluate the Effects of Two Novel Hydration Beverage Formulas on Rehydration in Healthy Adults". Dehydration lowers both physical and mental performance if it is severe enough. Performance declines are more pronounced in hot conditions or after prolonged strenuous activity such as exercise. Most individuals drink less than their sweat losses during activity, while some individuals overdrink and...
What is the current status of trial NCT05428761?
This trial is currently completed. It is a NA study. The enrollment target is 16 participants. The study started on 2022-08-01. Estimated completion is 2023-01-01.
What interventions are being tested in trial NCT05428761?
The interventions under investigation include: Placebo (OTHER), TP1 (OTHER), TP2 (OTHER).
Who is sponsoring clinical trial NCT05428761?
This trial is sponsored by Liquid I.V., which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.